miR-92a family and their target genes in tumorigenesis and metastasis.

The miR-92a family, including miR-25, miR-92a-1, miR-92a-2 and miR-363, arises from three different paralog clusters miR-17-92, miR-106a-363, and miR-106b-25 that are highly conservative in the process of evolution, and it was thought as a group of microRNAs (miRNAs) correlated with endothelial cells. Aberrant expression of miR-92a family was detected in multiple cancers, and the disturbance of miR-92a family was related with tumorigenesis and tumor development. In this review, the progress on the relationship between miR-92a family and their target genes and malignant tumors will be summarized.

[1]  J. Grillari,et al.  miR-17–92 cluster: ups and downs in cancer and aging , 2010, Biogerontology.

[2]  Sofie Nilsson,et al.  Downregulation of miR-92a Is Associated with Aggressive Breast Cancer Features and Increased Tumour Macrophage Infiltration , 2012, PloS one.

[3]  Tae Jin Lee,et al.  MicroRNAs/TP53 feedback circuitry in glioblastoma multiforme , 2012, Proceedings of the National Academy of Sciences.

[4]  C. Mendelson,et al.  The c-Myc-Regulated MicroRNA-17∼92 (miR-17∼92) and miR-106a∼363 Clusters Target hCYP19A1 and hGCM1 To Inhibit Human Trophoblast Differentiation , 2013, Molecular and Cellular Biology.

[5]  Qin Xu,et al.  Dysregulated miR-363 affects head and neck cancer invasion and metastasis by targeting podoplanin. , 2013, The international journal of biochemistry & cell biology.

[6]  H. Augustin,et al.  Histone Deacetylase 9 Promotes Angiogenesis by Targeting the Antiangiogenic MicroRNA-17–92 Cluster in Endothelial Cells , 2013, Arteriosclerosis, Thrombosis and Vascular Biology.

[7]  J. M. Thomson,et al.  Transgenic over-expression of the microRNA miR-17-92 cluster promotes proliferation and inhibits differentiation of lung epithelial progenitor cells. , 2007, Developmental biology.

[8]  Tara L. Naylor,et al.  microRNAs exhibit high frequency genomic alterations in human cancer. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[9]  J. DeGregori,et al.  The genetics of the E2F family of transcription factors: shared functions and unique roles. , 2002, Biochimica et biophysica acta.

[10]  Guangjun Zhang,et al.  Overexpression of miR-92a correlates with tumor metastasis and poor prognosis in patients with colorectal cancer , 2012, International Journal of Colorectal Disease.

[11]  John S. Mattick,et al.  Orthologous MicroRNA Genes Are Located in Cancer-Associated Genomic Regions in Human and Mouse , 2007, PloS one.

[12]  M. Santoro,et al.  miRNAs in endothelial cell signaling: the endomiRNAs. , 2013, Experimental cell research.

[13]  W. Linehan,et al.  Regulatory Effects of microRNA-92 (miR-92) on VHL Gene Expression and the Hypoxic Activation of miR-210 in Clear Cell Renal Cell Carcinoma , 2011, Journal of Cancer.

[14]  H. Ford,et al.  The miR-106b-25 cluster targets Smad7, activates TGF-β signaling, and induces EMT and tumor initiating cell characteristics downstream of Six1 in human breast cancer , 2012, Oncogene.

[15]  Kai Fu,et al.  The miR-17-92 microRNA cluster is regulated by multiple mechanisms in B-cell malignancies. , 2011, The American journal of pathology.

[16]  Aarati R. Ranade,et al.  MicroRNA 92a-2*: A Biomarker Predictive for Chemoresistance and Prognostic for Survival in Patients with Small Cell Lung Cancer , 2010, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[17]  C. Conti,et al.  E2F1 Has Both Oncogenic and Tumor-Suppressive Properties in a Transgenic Model , 1999, Molecular and Cellular Biology.

[18]  Yingjian Chen,et al.  Circulating microRNA-92a and microRNA-21 as novel minimally invasive biomarkers for primary breast cancer , 2012, Journal of Cancer Research and Clinical Oncology.

[19]  Stefanie Dimmeler,et al.  MicroRNA-92a Controls Angiogenesis and Functional Recovery of Ischemic Tissues in Mice , 2009, Science.

[20]  Justin L. Mott,et al.  miR‐25 targets TNF‐related apoptosis inducing ligand (TRAIL) death receptor‐4 and promotes apoptosis resistance in cholangiocarcinoma , 2012, Hepatology.

[21]  E. Li,et al.  Down‐regulated desmocollin‐2 promotes cell aggressiveness through redistributing adherens junctions and activating beta‐catenin signalling in oesophageal squamous cell carcinoma , 2013, The Journal of pathology.

[22]  Terry Hyslop,et al.  A cyclin D1/microRNA 17/20 regulatory feedback loop in control of breast cancer cell proliferation , 2008, The Journal of cell biology.

[23]  M. Loda,et al.  Identification of the miR-106b~25 MicroRNA Cluster as a Proto-Oncogenic PTEN-Targeting Intron That Cooperates with Its Host Gene MCM7 in Transformation , 2010, Science Signaling.

[24]  S. Lowe,et al.  A microRNA polycistron as a potential human oncogene , 2005, Nature.

[25]  Dara S. Missan,et al.  Integrin control of tumor invasion. , 2012, Critical reviews in eukaryotic gene expression.

[26]  Hongbing Shen,et al.  A Genetic Variant in the Promoter Region of miR-106b-25 Cluster and Risk of HBV Infection and Hepatocellular Carcinoma , 2012, PloS one.

[27]  Hiroyuki Tagawa,et al.  Identification and characterization of a novel gene, C13orf25, as a target for 13q31-q32 amplification in malignant lymphoma. , 2004, Cancer research.

[28]  D. Iliopoulos,et al.  E2F1-regulated microRNAs impair TGFbeta-dependent cell-cycle arrest and apoptosis in gastric cancer. , 2008, Cancer cell.

[29]  Kenichi Sugihara,et al.  Microarray Analysis of Colorectal Cancer Stromal Tissue Reveals Upregulation of Two Oncogenic miRNA Clusters , 2012, Clinical Cancer Research.

[30]  Scott A Gerber,et al.  Dicer-dependent endothelial microRNAs are necessary for postnatal angiogenesis , 2008, Proceedings of the National Academy of Sciences.

[31]  Zhaoli Chen,et al.  microRNA-92a Promotes Lymph Node Metastasis of Human Esophageal Squamous Cell Carcinoma via E-Cadherin* , 2010, The Journal of Biological Chemistry.

[32]  Rudolf Jaenisch,et al.  Targeted Deletion Reveals Essential and Overlapping Functions of the miR-17∼92 Family of miRNA Clusters , 2008, Cell.

[33]  S. Landais,et al.  Oncogenic potential of the miR-106-363 cluster and its implication in human T-cell leukemia. , 2007, Cancer research.

[34]  Yi-rong Wang,et al.  miR-92a is a critical regulator of the apoptosis pathway in glioblastoma with inverse expression of BCL2L11. , 2012, Oncology reports.

[35]  D. Mukhopadhyay,et al.  Aberrant regulation of pVHL levels by microRNA promotes the HIF/VEGF axis in CLL B cells. , 2009, Blood.

[36]  Qiang Zhou,et al.  TSA Suppresses miR-106b-93-25 Cluster Expression through Downregulation of MYC and Inhibits Proliferation and Induces Apoptosis in Human EMC , 2012, PloS one.

[37]  E. Lengyel,et al.  miR-92a inhibits peritoneal dissemination of ovarian cancer cells by inhibiting integrin α5 expression. , 2013, The American journal of pathology.

[38]  Vincent De Guire,et al.  An E2F/miR-20a Autoregulatory Feedback Loop* , 2007, Journal of Biological Chemistry.

[39]  Tanja Kunej,et al.  Epigenetic regulation of microRNAs in cancer: an integrated review of literature. , 2011, Mutation research.

[40]  C. Croce,et al.  A microRNA expression signature of human solid tumors defines cancer gene targets , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[41]  Xin Lu,et al.  MiR-25 regulates apoptosis by targeting Bim in human ovarian cancer. , 2011, Oncology reports.

[42]  L. Staudt,et al.  The miRNA-17∼92 cluster mediates chemoresistance and enhances tumor growth in mantle cell lymphoma via PI3K/AKT pathway activation , 2012, Leukemia.

[43]  J. Mendell.  miRiad Roles for the miR-17-92 Cluster in Development and Disease , 2008, Cell.

[44]  R. Quigg,et al.  miR-17-92 cluster accelerates adipocyte differentiation by negatively regulating tumor-suppressor Rb2/p130 , 2008, Proceedings of the National Academy of Sciences.

[45]  C. Croce,et al.  MicroRNA genes are frequently located near mouse cancer susceptibility loci , 2007, Proceedings of the National Academy of Sciences.

[46]  Masahiko Kuroda,et al.  Impact on cell to plasma ratio of miR-92a in patients with acute leukemia: in vivo assessment of cell to plasma ratio of miR-92a , 2010, BMC Research Notes.

[47]  Birgit Samans,et al.  MYCN regulates oncogenic MicroRNAs in neuroblastoma , 2007, International journal of cancer.

[48]  Y. Nagakawa,et al.  Deregulation of miR‐92a expression is implicated in hepatocellular carcinoma development , 2010, Pathology international.

[49]  S. Iida,et al.  Downregulated plasma miR-92a levels have clinical impact on multiple myeloma and related disorders , 2012, Blood Cancer Journal.

[50]  Lin He,et al.  mir-17-92, a cluster of miRNAs in the midst of the cancer network. , 2010, The international journal of biochemistry & cell biology.

[51]  Yong Li,et al.  Negative Regulation of the Tumor Suppressor p53 Gene by MicroRNAs , 2010, Oncogene.

[52]  Shinobu Ueda,et al.  miR‐92 is a key oncogenic component of the miR‐17–92 cluster in colon cancer , 2011, Cancer science.

[53]  R. Speich,et al.  Interleukin-6 Modulates the Expression of the Bone Morphogenic Protein Receptor Type II Through a Novel STAT3–microRNA Cluster 17/92 Pathway , 2009, Circulation research.

[54]  Masahiko Kuroda,et al.  Clinical Impact of Down-Regulated Plasma miR-92a Levels in Non-Hodgkin's Lymphoma , 2011, PloS one.

[55]  Avner Friedman,et al.  MicroRNA regulation of a cancer network: Consequences of the feedback loops involving miR-17-92, E2F, and Myc , 2008, Proceedings of the National Academy of Sciences.

[56]  Yibo Gao,et al.  MicroRNA-25 promotes cell migration and invasion in esophageal squamous cell carcinoma. , 2012, Biochemical and biophysical research communications.

[57]  C. Croce,et al.  Emerging role of miR-106b-25/miR-17-92 clusters in the control of transforming growth factor beta signaling. , 2008, Cancer research.

[58]  V. Narry Kim,et al.  Functional links between clustered microRNAs: suppression of cell-cycle inhibitors by microRNA clusters in gastric cancer , 2009, Nucleic acids research.

[59]  F. Sato,et al.  The miR-106b-25 polycistron, activated by genomic amplification, functions as an oncogene by suppressing p21 and Bim. , 2009, Gastroenterology.

[60]  R. Stallings,et al.  MicroRNA involvement in the pathogenesis of neuroblastoma: potential for microRNA mediated therapeutics. , 2009, Current pharmaceutical design.

[61]  Ying Tang,et al.  Repression of the miR‐17‐92 cluster by p53 has an important function in hypoxia‐induced apoptosis , 2009, The EMBO journal.